Exclusive to Dawaa News MENA | أخبار الدواء الشرق الأوسط
In a remarkable demonstration of industry leadership and collaboration, PharmaOverseas, Egypt’s leading pharmaceutical distribution company, held its annual gathering, which evolved into a strategic gathering of the most prominent figures shaping the country’s pharmaceutical landscape.
The event brought together an elite group of strategic partners, key stakeholders, and senior representatives from across Egypt’s pharmaceutical ecosystem — including officials from the Egyptian Drug Authority (EDA), the Unified Procurement Authority (UPA), and the Chamber of Pharmaceutical Industry. The distinguished presence reflected the depth of public–private collaboration driving Egypt’s healthcare sector forward, in an atmosphere of positivity and shared purpose.

Shared Commitment
The gathering reaffirmed the strong relationship between PharmaOverseas and Egypt’s pharmaceutical ecosystem, built on mutual trust and shared responsibility in serving the nation’s healthcare sector.
PharmaOverseas emphasized that its continued success stems from constructive collaboration with its partners and its unwavering dedication to quality, precision, and efficiency across every aspect of its operations.
Voices from the Sector
Dr. Tamer El-Husseiny, Deputy Chairman of the Egyptian Drug Authority, delivered a keynote address emphasizing the government’s unwavering commitment to ensuring access to safe, high-quality medicines for all Egyptians.
He commended PharmaOverseas for its adoption of modern technologies and innovative practices in pharmaceutical distribution, describing the company as one of the pillars of Egypt’s pharmaceutical ecosystem.

“PharmaOverseas plays a pivotal role in ensuring that every citizen across Egypt has access to effective and safe medicines. Its collaboration with the EDA contributes directly to enhancing healthcare quality and efficiency,” said Dr. El-Husseiny.
Dr. Gamal El-Leithy, Chairman of the Chamber of Pharmaceutical Industry, also addressed the audience, highlighting the state’s key role in supporting Egypt’s pharmaceutical manufacturing sector and fostering integration across the value chain.
He praised PharmaOverseas for its continuous contribution to the sector’s growth, noting:
“PharmaOverseas always stands out—it consistently comes up with creative and out-of-the-box ideas and initiatives.”

Commitment to Sustainable Growth
Dr. Mohab Gazzarine, Chairman of PharmaOverseas, emphasized that strategic partnerships lie at the core of the company’s sustainable growth.
“Our success is the collective result of our more than 9,000 dedicated employees and our constructive dialogue with all major industry stakeholders,” he stated.
Dr. Mohamed Gazzarine, CEO of Pharma Overseas, showcased the company’s latest milestones, noting its significant expansion to serve over 50,000 pharmacies nationwide.
He stressed the importance of offering a comprehensive product mix that meets diverse pharmacy needs, as well as introducing multiple electronic payment options to streamline operations and enhance customer convenience.
“We are fully committed to continuously improving our services, advancing digital solutions, and maintaining the highest standards of quality in medicine distribution,” Dr. Mohamed affirmed.
Looking Ahead: A Shared Vision for the Future
The annual gathering concluded with participants expressing deep appreciation for PharmaOverseas’ achievements and its role as a trusted national partner in the pharmaceutical supply chain.
Attendees highlighted the company’s ongoing innovation, reliability, and leadership, emphasizing that its continued progress will further strengthen the success of Egypt’s entire healthcare ecosystem. The evolution of PharmaOverseas is a testament to what strong partnerships can achieve — a future of shared growth, innovation, and excellence.
About PharmaOverseas
PharmaOverseas is Egypt’s leading pharmaceutical distribution company, serving more than 50,000 pharmacies nationwide through advanced logistics, technology-driven operations, and an unwavering commitment to quality and customer satisfaction. With a workforce exceeding 9,000 employees, the company plays a vital role in ensuring the safe, efficient, and timely delivery of medicines across the country.











